Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments

​[[{“value”:”

Ashwin Nandakumar and Ashwin Jainarayanan were working on their doctorates at adjacent departments in Oxford, but they didn’t know each other. Nandakumar, who was studying oncology, one day stumbled across a curious dataset for prostate cancer, with which he needed sequencing help. “I reached out to a few friends asking to help me analyze this […]

© 2024 TechCrunch. All rights reserved. For personal use only.

“}]]